Mitrotan (Ergometrine Maleate)

Ergometrine maleate, the active ingredient in Mitrotan, is an ergot alkaloid presented as an oral tablet for oral use. It is employed to prevent and treat postpartum hemorrhage and uterine atony in the obstetric setting. It is indicated for use in women after delivery when uterine contraction is insufficient, helping to reduce blood loss and stabilize hemodynamics.

GNH USA supplies Mitrotan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for global distribution.

Ergometrine maleate is used as a uterotonic to stimulate uterine smooth‑muscle contraction in obstetric care.

- Postpartum hemorrhage: reduces excessive bleeding by inducing sustained uterine contraction after delivery. - Uterine atony: restores tone in a relaxed uterus during or after childbirth. - Cesarean section uterine control: helps achieve hemostasis by contracting the uterus intra‑operatively.

Ergometrine maleate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Headache: transient cranial discomfort. - Hypertension: temporary increase in blood pressure. - Abdominal cramping: uterine pain.

Serious or Rare Side Effects: - Severe hypertension: risk of hypertensive crisis. - Cardiac arrhythmia: irregular heart rhythm. - Pulmonary edema: fluid accumulation in lungs.

When prescribing Mitrotan, clinicians should observe several safety considerations.

- Assess cardiovascular status: evaluate blood pressure before administration. - Monitor for uterine hyperstimulation: watch for excessive contractions. - Use with caution in patients with pre‑eclampsia: risk of worsening hypertension. - Avoid in known hypersensitivity to ergot alkaloids: may trigger allergic reactions. - Review concomitant vasoconstrictive drugs: potential additive effects. - Store at ambient temperature: keep below 25 °C, protect from moisture and light.

Ergometrine maleate can interact with several medication classes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): can cause severe hypertension. - Ergot‑derived vasoconstrictors (e.g., ergotamine): additive vasospasm risk. - Sympathomimetic agents (e.g., epinephrine): may precipitate hypertensive emergencies.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: may blunt desired blood pressure rise. - Calcium channel blockers: potential for altered uterine response. - Antidepressants affecting serotonin (SSRIs): monitor for serotonergic effects.